Waldencast plc

Waldencast plc

WALD·NASDAQ

$1.71

-7.1%
TechnologySoftware - Application

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

At a Glance

Live Snapshot
Market Cap$202.19M
EPS-2.0100
P/E Ratio-0.85
Earnings Date05/11/2026
wald

Waldencast plc Street Expectations Map

WALD · NASDAQ

Wall Street analysts project that WALD stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 2.50, with estimates ranging from a low of 2.00 to a high of 3.00.

Lowest Target
2.00
16.96%
Consensus Target
2.50
46.20%
Highest Target
3.00
75.44%

The consensus 1-year price target stands at 2.50, with estimates ranging from a low of 2.00 to a high of 3.00.

Analyst Consensus Analysis

Upside Potential

+46.2%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

40.0% spread

Mixed analyst views. Wide target range suggests differing opinions on key value drivers, growth prospects, or risk factors.

Analyst Conviction

Moderate

Neutral sentiment. Fair value pricing with moderate agreement suggests wait-and-see approach or catalyst-driven opportunity.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

wald

Waldencast plc Forward Estimates of Revenue

WALD · NASDAQ
Latest Revenue
272.07M
FY 2025
Avg Estimate
291.91M
FY 2026
Estimate Range
283.54M - 300.28M
Analyst Spread

Forward Growth Analysis

Projected Growth+7.3%

Moderate growth expected, typical for mature businesses with stable market positions.

Analyst Coverage3 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread6%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

wald

Waldencast plc Forward Estimates of Net Income

WALD · NASDAQ
Latest Net Income
-229.75M
FY 2025
Avg Estimate
-69.12M
FY 2026
Estimate Range
-72.87M - -65.37M
Analyst Spread

Forward Growth Analysis

Projected Growth+69.9%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage3 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread11%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

wald

Waldencast plc Forward Estimates of EPS

WALD · NASDAQ
Latest EPS
-2.01
FY 2025
Avg Estimate
$-0.61
FY 2026
Estimate Range
$-0.64 - $-0.57
Analyst Spread

Forward Growth Analysis

Projected Growth+69.5%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread11%

Reasonable estimate spread indicates general agreement with normal forecast variance.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

wald

Waldencast plc Forward Estimates of EBIT

WALD · NASDAQ
Latest EBIT
-61.67M
FY 2025
Avg Estimate
-91.86M
FY 2026
Estimate Range
-94.50M - -89.23M
Analyst Spread

Forward Growth Analysis

Projected Growth-48.9%

Significant contraction projected—major business challenges or industry disruption likely.

Analyst Coverage3 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread6%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

wald

Waldencast plc Forward Estimates of EBITDA

WALD · NASDAQ
Latest EBITDA
-2.49M
FY 2025
Avg Estimate
-32.12M
FY 2026
Estimate Range
-33.04M - -31.20M
Analyst Spread

Forward Growth Analysis

Projected Growth-1189.4%

Significant contraction projected—major business challenges or industry disruption likely.

Analyst Coverage3 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread6%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signals—some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

wald

Waldencast plc Forward Estimates of SG&A Expense

WALD · NASDAQ
Latest SG&A Expense
185.51M
FY 2025
Avg Estimate
218.82M
FY 2026
Estimate Range
212.55M - 225.10M
Analyst Spread

Forward Growth Analysis

Projected Growth+18.0%

Solid growth trajectory indicates healthy business performance and competitive positioning.

Analyst Coverage3 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread6%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

wald

Waldencast plc Insider Positioning

WALD · NASDAQ

During the last 12 months, there has been no insider trading activity reported for WALD.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Neutral

No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.

Insider Participation

No Activity

No insider trading activity reported from any insiders in the past year.